Skip to main content

Newsroom

Please see below links to the most recent news and events for IDEAYA.

 

Media Contacts News Alerts LinkedIn

 
Latest Press
Sep 27, 2023

Fast Track designation granted by U.S. FDA for evaluation of IDE161 in adult patients with HR+, Her2-, BRCA1/2 mutant advanced or metastatic breast cancer patients who have been pretreated with...

Sep 26, 2023

Fast Track designation granted by U.S. FDA for evaluation of IDE161 in adult patients with BRCA1/2 mutant advanced or metastatic ovarian cancer who are platinum resistant and have received prior...

Sep 11, 2023

Initiated IDE161 Phase 1 expansion based on preliminary tumor shrinkage observed in multiple HRD solid tumor patients, including an endometrial cancer subject with a first imaging assessment of a...

All News

Featured Stories
Stay up-to-date with us
GET EMAIL ALERTS
* Required Fields
Close Menu